ENDOR AG/ DE0005491666 /
5/24/2024 6:10:40 PM | Chg. -0.050 | Volume | Bid9:59:19 PM | Ask9:59:19 PM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
0.186EUR | -21.19% | 35,530 Turnover: 6,756.260 |
-Bid Size: - | -Ask Size: - | 2.88 mill.EUR | - | 0.93 |
GlobeNewswire
3/28
CIO Leadership: Celebrating Charlie Feld and Other Recipients of HMG Strategy’s Global Leadership In...
GlobeNewswire
5/1/2020
SHAREHOLDER ALERT: WeissLaw LLP Reminds NTGN, SBBX, QUMU, and MSBF Shareholders About Its Ongoing In...
GlobeNewswire
4/28/2020
Rigrodsky & Long, P.A. Files Class Action Suit Against Neon Therapeutics, Inc.
GlobeNewswire
4/24/2020
SHAREHOLDER ALERT: WeissLaw LLP Reminds NTGN, SBBX, QUMU, and MSBF Shareholders About Its Ongoing In...
GlobeNewswire
4/17/2020
SHAREHOLDER ALERT: WeissLaw LLP Reminds NTGN, MSBF, QUMU and SBBX Shareholders About Its Ongoing Inv...
GlobeNewswire
3/2/2020
Neon Therapeutics Reports Fourth Quarter and Full Year 2019 Financial Results and Provides Business ...
GlobeNewswire
1/16/2020
BioNTech to acquire Neon to strengthen global leadership position in T cell therapies
GlobeNewswire
1/16/2020
BioNTech to acquire Neon to strengthen global leadership position in T cell therapies